Trodelvy is an exciting new drug that could give certain women living with incurable triple negative secondary breast cancer the hope of more time. More time to enjoy with loved ones and to do things that matter most to them.

However, they’re facing an agonising wait until it becomes available on the NHS.

That’s why we have launched our #TimeForTrodelvy petition calling on the drug company, Gilead, to provide it free of charge, until a decision is made about its routine use on the NHS.

Sign the petition

If we're going to put pressure on Gilead to do the right thing, we need as many people as possible to add their names to the petition.

The more support we have, the better our chances of success. For patients, Trodelvy could be life-changing. These women have no time to lose.

Please sign our petition now and help us turn the tide on triple negative secondary breast cancer.

We don’t have time for delays, we don’t have time to wait. It’s Time for Trodelvy.

To know this drug is there but may not be available to women quickly is terrible – women will therefore die whilst waiting for it – it’s simply unjust. It really frightens me that it might not be available when I need it.

Philippa, diagnosed with triple negative secondary breast cancer in 2020

Frequently asked questions

Sign the petition

Please join our call and sign the petition today.

We don’t have time for delays, we don’t have time to wait. It’s #TimeforTrodelvy.

Sign the petition